Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-403-1 | CAS number: 106-49-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
OECD SIDS 2005
p-Toluidine does not induce point mutations in the vast majority of in-vitro Ames test. In Chinese hamster lung cells p-toluidine is clastogenic in the presence but not in the absence of S9-mix. In vivo, DNA single strand breaks are detected in liver and kidneys of mice using alkaline-elution technique after single intraperitoneal injection of (35 mg/kg bw), therefore it cannot be decided definitely whether the effects occurred due to cytotoxicity or real genotoxic mechanisms.
Overall, there is some indication for clastogenic activity in vitro and some residual suspicion for such action in vivo. In mammalian cell systems (chromosomal aberration) for p-toluidine - but not for m-toluidine - there is some indication for clastogenic activity in vitro
m-Toluidine is not genotoxic because of negative results in bacterial experiments (Salmonella typhimurium TA98, TA100, TA1535, TA 1537, TA1538, G46, C3076, D3052, Escherichia coli WP2 and WP2uvrA with or without an exogenous metabolic activation system) and mammalian in vitro tests according to OECD TG 473 (chromosomal aberration in Chinese hamster lung (CHL) cells) as well as in vivo experiments. The four available in vivo genotoxicity studies could not be adopted as the robust study due to the lack of detailed data. Their types were sister chromatid exchange and inhibition of DNA-synthesis. All results were negative (UNEP, 2003).
Overall conclusion
Both, p- and m-toluidine are not mutagenic to Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and to Escherichia coli strain WP2uvrA with and without addition of rat liver S9 mix.
p-Toluidine was positive in Salmonella typhimurium TA 100 in the presence of hamster liver S9 mix; m-toluidine was inactive under these conditions. In mammalian cell systems (chromosomal aberration) for p-toluidine - but not for m-toluidine - there is some indication for clastogenic activity in vitro
Short description of key information:
OECD-SIDS, 2005
In vitro Studies
In 1996 and 1997 JETOC reported standard Ames-test (preincubation methodology) with p-toluidine using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and Escherichia coli WP2urA (with and without rat liver S9-mix) and concentrations ranging between 0.0 and 5000 µg/mL with negative results. In 1997 JETOC reported additionally Salmonella typhimurium TA102 and TA104 and Escherichia coli WP2urA/pKM101 (0 - 5000 µg/mL) yielding also negative results. Positive controls were reported to be functional in both publications. Zeiger et al. (1992) did not find mutagenic activity in concentrations ranging between 0 and 3333 µg/plate using Salmonella typhimurium TA97, TA98 and TA1535 without metabolic activation and in the presence of hamster or rat liver S9-mix. Salmonella typhimurium TA100 was tested negative without metabolic activation and in the presence of rat liver S9-mix but was positive in the presence of hamster liver S9-mix. Concurrent positive controls were always functional (Zeiger et al., 1992).
p-Toluidine was tested for clastogenicity in Chinese hamster lung cells in the presence and in the absence of an exogen metabolic activation system. Test concentrations ranged from 12.5 µg/mL up to 50 µg/mL (Ishidate, 1988) and up to 1000 µg/mL (Ishidate, Harnois and Sofuni, 1988), respectively.
Cytotoxicity was determined in preliminary tests with and without S9-mix, in the presence of S9-mix from 25 µg/mL onward (Ishidate, 1988). In both reports induction of chromosomal aberrations were only observed in the presence of S9-mix (from12.5 µg/mL (Ishidate, 1988) and from 500 µg/mL (Ishidate, Harnois and Sofuni, 1988), respectively) but not in the absence of the metabolic activation system.
In vivo Studies
Single intraperitoneal injection of 35 mg/kg bw into male Swiss mice caused significant increases in DNA-single strand breaks in the nuclei of liver and kidney which were prepared 4 hours after application and measured by alkal...
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.